The National Institute of Biomedical Imaging and Bioengineering awarded a $214,600 Project Grant (CFDA 93.286) to Akna Health Inc. in Grand Rapids, MI on September 2, 2024. The objective of the research project is to develop a pioneering diagnostic solution for early identification of perinatal risks using cervical biomarkers. Key activities include systematic collection and analysis of cervical and blood specimens from 200 high-risk pregnancies to evaluate the clinical relevance of placental biomarkers. The project aims to establish robust correlations between cervical biomarker levels and pregnancy outcomes, laying the groundwork for a more comprehensive clinical validation study. If successful, this work could lead to a cutting-edge point-of-care diagnostic kit that can enhance early interventions and improve outcomes for a significant portion of high-risk pregnancies.
Generated 3/18/25, 5:18 AM